Bionano Genomics Inc (BNGO)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current BNGO market cap is 529.34M. The company's latest EPS is USD -2.2795 and P/E is -2.26.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 9.32M | 10.72M | 8.77M | 7.77M | 6.07M |
| Operating Income | -113.21M | -24.95M | -31.12M | -17.02M | -43.9M |
| Net Income | -112.56M | -43.89M | -31.42M | -16.22M | -44.25M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 10.13M | 8.5M | 17.98M | 27.8M | 36.12M |
| Operating Income | -25.87M | -38.55M | -77.1M | -131.7M | -215.25M |
| Net Income | -29.82M | -41.11M | -72.44M | -132.6M | -232.49M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 181.9M | 214.4M | 158M | 129.36M | 87.36M |
| Total Liabilities | 62.91M | 118.25M | 75.22M | 49.03M | 38.49M |
| Total Equity | 119M | 96.16M | 82.77M | 80.34M | 48.87M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 30.21M | 60.45M | 377.1M | 307.5M | 214.4M |
| Total Liabilities | 26.59M | 25.37M | 39.98M | 58.1M | 118.25M |
| Total Equity | 3.61M | 35.08M | 337.12M | 249.4M | 96.16M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -95.4M | -125.18M | -28.13M | -49.11M | -62.42M |
| Investing | 79.53M | 24.16M | 47.59M | 76.22M | 70.84M |
| Financing | 45.33M | 113.82M | -21.62M | -23.6M | -17.58M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -29.53M | -38.31M | -71.93M | -124.82M | -125.18M |
| Investing | -61k | -2.45M | -278.06M | 82.77M | 24.16M |
| Financing | 30.38M | 61.9M | 336.11M | 23.01M | 113.82M |
| Market Cap | 529.34M |
| Price to Earnings Ratio | -2.26 |
| Price to Sales Ratio | 14.54 |
| Price to Cash Ratio | 29.26 |
| Price to Book Ratio | 5.46 |
| Dividend Yield | - |
| Shares Outstanding | 101.99M |
| Average Volume (1 week) | 3.78M |
| Average Volume (1 Month) | 14.5M |
| 52 Week Change | 315.20% |
| 52 Week High | 6.98 |
| 52 Week Low | 0.1156 |
| Spread (Intraday) | 0.07 (1.35%) |
| Company Name | Bionano Genomics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.bionanogenomics.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
